marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2025-Q2
added 08-13-2025
Aethlon Medical Cost of Revenue 2011-2025 | AEMD
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.87 M | 5.21 M | 4.44 M | 4.63 M | 3.45 M | 2.3 M | 3.08 M | 2.63 M | 3.48 M | 2.08 M | 2.28 M | 2.23 M | 2.17 M | 2.05 M | 2.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.21 M | 2.05 M | 3.12 M |
Quarterly Cost of Revenue Aethlon Medical
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 581 K | - | 620 K | 1.37 M | 1.25 M | - | 1.92 M | 1.19 M | 1.12 M | - | 1.05 M | 1.11 M | 1.03 M | - | 1 M | 2.82 M | 1.82 M | - | 1.52 M | 1.52 M | 560 K | 437 K | 406 K | 406 K | 598 K | 606 K | 1.16 M | 1.16 M | 672 K | - | 663 K | 618 K | 630 K | - | 636 K | 2.79 M | 2.16 M | - | 615 K | 1.67 M | 1.06 M | - | 571 K | 1.74 M | 1.17 M | - | 425 K | 1.29 M | 863 K | - | 507 K | 1.62 M | 1.11 M | - | 488 K | 1.55 M | 1.07 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.82 M | 406 K | 1.09 M |
Cost of Revenue of other stocks in the Medical devices industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
21.4 M | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
13.7 M | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
197 M | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Pulmonx Corporation
LUNG
|
21.8 M | $ 1.98 | 26.92 % | $ 77.4 M | USA |
 |
Medtronic PLC
MDT
|
11.6 B | $ 93.23 | -0.96 % | $ 120 B | USA |
 |
Cardiovascular Systems
CSII
|
63.4 M | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Neovasc
NVCN
|
556 K | $ 30.03 | - | $ 111 M |  Canada |
 |
Apollo Endosurgery
APEN
|
34.4 M | $ 10.0 | - | $ 475 M | USA |
 |
Viveve Medical
VIVE
|
5.81 M | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Invacare Corporation
IVC
|
566 M | $ 0.66 | - | $ 24.7 M | USA |
 |
Abiomed
ABMD
|
162 M | $ 381.02 | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
24.5 M | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
Quanterix Corporation
QTRX
|
51.7 M | $ 5.48 | -3.52 % | $ 206 M | USA |
 |
AVITA Medical
RCEL
|
9.09 M | $ 3.66 | -3.43 % | $ 94.7 M |  Australia |
 |
Sintx Technologies
SINT
|
784 K | $ 3.46 | -4.68 % | $ 12.9 M | USA |
 |
ShockWave Medical
SWAV
|
95.4 M | $ 334.75 | - | $ 12.3 B | USA |
 |
SeaSpine Holdings Corporation
SPNE
|
76.9 M | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
92.2 M | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Bruker Corporation
BRKR
|
1.72 B | $ 38.72 | 0.21 % | $ 5.77 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
76 M | $ 70.98 | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
32.4 M | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
23 M | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
6.19 M | $ 10.15 | 1.6 % | $ 289 M | USA |
 |
Viemed Healthcare
VMD
|
70.2 M | $ 6.86 | -1.29 % | $ 263 M | USA |
 |
SmileDirectClub
SDC
|
143 M | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
Globus Medical
GMED
|
1.04 B | $ 62.75 | -0.77 % | $ 8.52 B | USA |
 |
ThermoGenesis Holdings
THMO
|
7.77 M | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
10.3 M | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
12.3 M | $ 26.98 | 5.97 % | $ 729 M | USA |
 |
Surgalign Holdings
SRGA
|
41.7 M | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
38.8 M | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
36.3 M | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
337 M | $ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
171 M | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
75.3 K | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
40.4 M | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Beyond Air
XAIR
|
5.37 M | $ 2.1 | 0.96 % | $ 142 M | USA |
 |
Talis Biomedical Corporation
TLIS
|
41 K | $ 4.38 | 3.55 % | $ 7.96 M | USA |